1 DAVISON A J, EBERLE R, EHLERS B, HAYWARD G S, MCGEOCH D J, MINSON A C, PELLETT P E, ROIZMAN B, STUDDERT M J, THIRY E. The order Herpesvirales. Archives of virology[J]. 2009,154(1):171-177.
2 CALNEK B W. Marek's disease--a model for herpesvirus oncology. Critical reviews in microbiology[J]. 1986,12(4):293-320.
3 OSTERRIEDER N, KAMIL J P, SCHUMACHER D, TISCHER B K, TRAPP S. Marek's disease virus: from miasma to model. Nature reviews Microbiology[J]. 2006,4(4):283-294.
4 NEERUKONDA S N, TAVLARIDES-HONTZ P, MCCARTHY F, PENDARVIS K, PARCELLS M S. Comparison of the Transcriptomes and Proteomes of Serum Exosomes from Marek's Disease Virus-Vaccinated and Protected and Lymphoma-Bearing Chickens. Genes (Basel)[J]. 2019,10(2).
5 WITTER R L. Increased virulence of Marek's disease virus field isolates. Avian diseases[J]. 1997,41(1):149-163.
6 ROZINS C, DAY T. The industrialization of farming may be driving virulence evolution. Evolutionary applications[J]. 2017,10(2):189-198.
7 NAIR V. Spotlight on avian pathology: Marek's disease. Avian pathology : journal of the WVPA[J]. 2018,47(5):440-442.
8 YU Z H, TENG M, LUO J, WANG X W, DING K, YU L L, SU J W, CHI J Q, ZHAO P, HU B, ZHANG G P, LIU J X. Molecular characteristics and evolutionary analysis of field Marek's disease virus prevalent in vaccinated chicken flocks in recent years in China. Virus genes[J]. 2013,47(2):282-291.
9 MOLES R. MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment. Microrna[J]. 2017,6(2):102-109.
10 SHIRJANG S, MANSOORI B, ASGHARI S, DUIJF P H G, MOHAMMADI A, GJERSTORFF M, BARADARAN B. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. Free radical biology & medicine[J]. 2019,139:1-15.
11 WANG J, WANG B, REN H, CHEN W. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Biochemical and biophysical research communications[J]. 2019,509(1):241-248.
12 ZHAI S, ZHAO L, LIN T, WANG W. Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth. Journal of cellular biochemistry[J]. 2019,120(4):6651-6660.
13 SUBRAMANIAM S, JEET V, CLEMENTS J A, GUNTER J H, BATRA J. Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism. Clinical chemistry[J]. 2019,65(9):1090-1101.
14 TENG M, YU Z H, ZHAO P, ZHUANG G Q, WU Z X, DANG L, LI H Z, MA S M, CUI Z Z, ZHANG G P, WU R, LUO J. Putative roles as oncogene or tumour suppressor of the Mid-clustered microRNAs in Gallid alphaherpesvirus 2 (GaHV2) induced Marek's disease lymphomagenesis. The Journal of general virology[J]. 2017,98(5):1097-1112.
15 TENG M, YU Z H, SUN A J, MIN Y J, CHI J Q, ZHAO P, SU J W, CUI Z Z, ZHANG G P, LUO J. The significance of the individual Meq-clustered miRNAs of Marek's disease virus in oncogenesis. The Journal of general virology[J]. 2015,96(Pt 3):637-649.
16 YU Z H, TENG M, SUN A J, YU L L, HU B, QU L H, DING K, CHENG X C, LIU J X, CUI Z Z, ZHANG G P, LUO J. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus. Virology[J]. 2014,448:55-64.
17 CHI J Q, TENG M, YU Z H, XU H, SU J W, ZHAO P, XING G X, LIANG H D, DENG R G, QU L H, ZHANG G P, LUO J. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-beta signaling pathway. Virology[J]. 2015,476:72-84.
18 LIU N, JIANG F, HAN X Y, LI M, CHEN W J, LIU Q C, LIAO C X, LV Y F. MiRNA-155 promotes the invasion of colorectal cancer SW-480 cells through regulating the Wnt/beta-catenin. European review for medical and pharmacological sciences[J]. 2018,22(1):101-109.
19 LIU K, ZHAO K, WANG L, SUN E. Prognostic value of microRNA-155 in human carcinomas: An updated meta-analysis. Clinica chimica acta; international journal of clinical chemistry[J].2018, 479:171-180.
20 HOU Y, WANG J, WANG X, SHI S, WANG W, CHEN Z. Appraising MicroRNA-155 as a noninvasive diagnostic biomarker for cancer detection: A meta-analysis. Medicine[J]. 2016,95(2):e2450.
21 WU X, CHEN B A. Influence of miRNA-155 on lymphoma. Zhongguo shi yan xue ye xue za zhi[J]. 2013,21(3):806-809.
22 ZHUANG G, SUN A, TENG M, LUO J. A Tiny RNA that Packs a Big Punch: The critical role of a viral miR-155 ortholog in lymphomagenesis in Marek's Disease. Frontiers in microbiology[J]. 2017,8:1169.
23 ZHAO Y, YAO Y, XU H, LAMBETH L, SMITH L P, KGOSANA L, WANG X, NAIR V. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. Journal of virology[J]. 2009,83(1):489-492.
24 ZHAO Y, XU H, YAO Y, SMITH L P, KGOSANA L, GREEN J, PETHERBRIDGE L, BAIGENT S J, NAIR V. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS pathogens[J]. 2011,7(2):e1001305.
25 ZHANG Y, TANG N, LUO J, TENG M, MOFFAT K, SHEN Z, WATSON M, NAIR V, YAO Y. Marek's Disease Virus-encoded microRNA 155 ortholog critical for the induction of lymphomas Is not essential for the proliferation of transformed cell lines. Journal of virology[J]. 2019,93(17): e00713-19.
26 BONDADA M S, YAO Y, NAIR V. Multifunctional miR-155 pathway in avian oncogenic virus-induced neoplastic diseases. Non-coding RNA[J]. 2019,5(1):24-36.
27 YAO Y, ZHAO Y, XU H, SMITH L P, LAWRIE C H, WATSON M, NAIR V. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. Journal of virology[J]. 2008,82(8):4007-4015.
28 LUO J, SUN A J, TENG M, ZHOU H, CUI Z Z, QU L H, ZHANG G P. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease. The Journal of general virology[J]. 2011,92(Pt 3):608-620.
29 YAO Y, ZHAO Y, SMITH L P, LAWRIE C H, SAUNDERS N J, WATSON M, NAIR V. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. The Journal of general virology[J]. 2009,90(Pt 7):1551-1559.
30 LIAN L, QU L, CHEN Y, LAMONT S J, YANG N. A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs. PloS one[J]. 2012,7(11):e51003.
31 XU H, YAO Y, SMITH L P, NAIR V. MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines. Cancer cell international[J]. 2010,10:15-21.
32 PARNAS O, CORCORAN D L, CULLEN B R. Analysis of the mRNA targetome of microRNAs expressed by Marek's disease virus. mBio[J]. 2014,5(1):e01060-01013.
33 KROL J, LOEDIGE I, FILIPOWICZ W. The widespread regulation of microRNA biogenesis, function and decay. Nature reviews Genetics[J]. 2010,11(9):597-610.
34 WANG Y, CONG W, WU G, JU X, LI Z, DUAN X, WANG X, GAO H. MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc. Cell biology international[J]. 2018,42(1):25-33.
35 GU J, LU Z, JI C, CHEN Y, LIU Y, LEI Z, WANG L, ZHANG H T, LI X. Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie[J]. 2017,93:969-975.
36 WEI R J, ZHANG C H, YANG W Z. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3beta/beta-catenin signaling pathway. European review for medical and pharmacological sciences[J]. 2017,21(22):5034-5041.
37 YAN Z, CHE S, WANG J, JIAO Y, WANG C, MENG Q. miR-155 contributes to the progression of glioma by enhancing Wnt/beta-catenin pathway. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine[J]. 2015,36(7):5323-5331.
38 LIU F, SONG D, WU Y, LIU X, ZHU J, TANG Y. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer. Thoracic cancer[J]. 2017,8(6):613-619.
39 AL-HAIDARI A, ALGABER A, MADHI R, SYK I, THORLACIUS H. MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR). Cancer letters[J]. 2018,421:145-151.
40 AL-HAIDARI A A, SYK I, THORLACIUS H. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA. Oncotarget[J]. 2017,8(9):14887-14896.
41 ZHAO X S, HAN B, ZHAO J X, TAO N, DONG C Y. MiR-155-5p affects Wilms' tumor cell proliferation and apoptosis via targeting CREB1. European review for medical and pharmacological sciences[J]. 2019,23(3):1030-1037.
42 LI S, ZHANG T, ZHOU X, DU Z, CHEN F, LUO J, LIU Q. The tumor suppressor role of miR-155-5p in gastric cancer. Oncology letters[J]. 2018,16(2):2709-2714.
43 GUO T, WANG X X, FU H, TANG Y C, MENG B Q, CHEN C H. Early diagnostic role of PSA combined miR-155 detection in prostate cancer. European review for medical and pharmacological sciences[J]. 2018,22(6):1615-1621.
44 WANG F, SHAN S, HUO Y, XIE Z, FANG Y, QI Z, CHEN F, LI Y, SUN B. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer. The international journal of biochemistry & cell biology[J]. 2018,99:91-99.
45 COOK D N, KANG H S, JETTEN A M. Retinoic acid-related orphan receptors (RORs): Regulatory functions in immunity, development, circadian rhythm, and metabolism. Nuclear receptor research[J]. 2015,2.
46 JETTEN A M, KANG H S, TAKEDA Y. Retinoic acid-related orphan receptors alpha and gamma: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivity. Frontiers in endocrinology[J]. 2013,4:1.
47 SUN X, DONGOL S, QIU C, XU Y, SUN C, ZHANG Z, YANG X, ZHANG Q, KONG B. miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer. Molecular cancer research : MCR[J]. 2018,16(12):1927-1939.
48 TAHERI M, OMRANI M D, NOROOZI R, GHAFOURI-FARD S, SAYAD A. Retinoic acid-related orphan receptor alpha (RORA) variants and risk of breast cancer. Breast disease[J]. 2017,37(1):21-25.
49 CHANG Y, CUI M, FU X, ZHANG L, LI X, LI L, WU J, SUN Z, ZHANG X, LI Z, NAN F, YAN J, ZHANG M. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1. Cancer biology & therapy[J]. 2019,20(1):31-41.
50 JI W G, ZHANG X D, SUN X D, WANG X Q, CHANG B P, ZHANG M Z. miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene. Journal of Huazhong University of Science and Technology Medical sciences [J]. 2014,34(6):882-888.
51 WANG D, TANG M, ZONG P, LIU H, ZHANG T, LIU Y, ZHAO Y. MiRNA-155 Regulates the Th17/Treg Ratio by Targeting SOCS1 in Severe Acute Pancreatitis. Frontiers in physiology[J]. 2018,9:686.